US · Healthcare

Cognetivity Neurosciences Ltd (CGNSF)

Health Information Services

Cognetivity Neurosciences Ltd (CGNSF) is listed on US in the Healthcare sector. Industry: Health Information Services. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CGNSF

P/E ratio

18.00

Cognetivity Neurosciences Ltd (CGNSF) — FAQ

What is CGNSF's P/E ratio?

The price-to-earnings (P/E) ratio for Cognetivity Neurosciences Ltd (CGNSF) is 18.00 (data as of 2026-03-23).

Does Cognetivity Neurosciences Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Cognetivity Neurosciences Ltd (CGNSF). Check the MyAverix Finance app for the latest dividend data.

What sector is Cognetivity Neurosciences Ltd in?

Cognetivity Neurosciences Ltd (CGNSF) is classified in the Healthcare sector (Health Information Services industry).

What exchange is CGNSF listed on?

CGNSF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)